Hello Hiteshji,
Prospect wise and basing on their filings and pipeline, isn’t Natco Pharma a much better bet in the Oncology space as compared to FK or Shilpa ??
Natco is expensive, but the chances of positive surprises are more there.
Hello Hiteshji,
Prospect wise and basing on their filings and pipeline, isn’t Natco Pharma a much better bet in the Oncology space as compared to FK or Shilpa ??
Natco is expensive, but the chances of positive surprises are more there.